|
Market Closed -
Nasdaq
16:00:00 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 3.130 USD | -6.57% |
|
-15.41% | -9.80% |
| Market Cap | 596M 513M 486M 441M 827M 56.94B 831M 5.77B 2.22B 28.97B 2.24B 2.19B 91.53B | P/E 2026 * |
-3.17x | P/E 2027 * | -3.32x |
|---|---|---|---|---|---|
| Enterprise Value | 564M 486M 460M 417M 782M 53.88B 786M 5.47B 2.1B 27.41B 2.12B 2.07B 86.63B | EV / Sales 2026 * |
47.9x | EV / Sales 2027 * | 33.4x |
| Free-Float |
76.34% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| PRME | Delayed | |
CBOE
| PRME | Real-time |
Last Transcript : Prime Medicine, Inc.
| 1 day | -6.57% | ||
| 1 week | -15.41% | ||
| Current month | -12.81% | ||
| 1 month | -3.99% | ||
| 3 months | +10.99% | ||
| 6 months | -18.28% | ||
| Current year | -9.80% |
| 1 week | 3.1 |  | 3.65 |
| 1 month | 3 | | 3.86 |
| Current year | 2.67 | | 4.82 |
| 1 year | 2.67 | | 6.94 |
| 3 years | 1.11 | | 13.27 |
| 5 years | 1.11 | | 21.73 |
| 10 years | 1.11 | | 21.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
Andrew Anzalone
PRN | Corporate Officer/Principal | 39 | 2019-09-12 |
Allan Reine
CEO | Chief Executive Officer | 51 | 2025-05-18 |
Svetlana Makhni
DFI | Director of Finance/CFO | 42 | 2026-04-15 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Nelsen
BRD | Director/Board Member | 62 | 2020-08-31 |
David Schenkein
BRD | Director/Board Member | 68 | 2019-09-12 |
Wendy Chung
BRD | Director/Board Member | 57 | 2021-10-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/5/26 | Free | Director | 75,000 | 0.0435% | ||
| 4/16/26 | Free | Chief Financial Officer | 800,000 | 0.4638% | ||
| 2/26/26 | Free | Chief Executive Officer | 1,300,000 | 0.7536% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.57% | -15.41% | -23.28% | -75.37% | 596M | |
| -2.11% | -3.44% | +41.04% | +98.48% | 68.24B | |
| -0.23% | -4.45% | +30.39% | +73.64% | 62.23B | |
| +1.67% | +2.47% | -11.23% | +388.34% | 27.8B | |
| -1.05% | -7.30% | +25.00% | +12.31% | 24.86B | |
| +0.34% | -6.78% | -7.27% | -17.99% | 24.22B | |
| +0.43% | -4.78% | +18.26% | -20.61% | 19.36B | |
| -3.03% | -5.19% | +192.88% | +340.13% | 17.28B | |
| -1.94% | -6.36% | -7.05% | +516.16% | 14.46B | |
| -2.28% | -4.90% | +43.64% | +155.21% | 14.23B | |
| Average | -1.48% | -4.53% | +30.24% | +147.03% | 27.33B | |
| Weighted average by Cap. | -0.87% | -3.82% | +33.00% | +135.67% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 11.77M 10.14M 9.6M 8.7M 16.32M 1.12B 16.4M 114M 43.84M 572M 44.18M 43.22M 1.81B | 13.38M 11.53M 10.92M 9.9M 18.56M 1.28B 18.66M 130M 49.86M 650M 50.26M 49.16M 2.06B |
| Net income | -182M -157M -148M -135M -252M -17.38B -254M -1.76B -678M -8.84B -683M -668M -27.94B | -204M -175M -166M -151M -283M -19.46B -284M -1.97B -759M -9.9B -765M -748M -31.28B |
| Net Debt | -31.95M -27.53M -26.07M -23.63M -44.33M -3.05B -44.55M -310M -119M -1.55B -120M -117M -4.91B | -149M -128M -121M -110M -206M -14.21B -207M -1.44B -554M -7.23B -558M -546M -22.84B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-11 | US$3.130 | -6.57% | 3,075,852 |
| 26-09-10 | US$3.350 | -3.46% | 2,390,206 |
| 26-09-09 | US$3.470 | -2.53% | 4,225,349 |
| 26-09-08 | US$3.560 | -3.78% | 3,602,081 |
| 26-09-04 | US$3.700 | -0.27% | 1,619,295 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PRME Stock
Select your edition
All financial news and data tailored to specific country editions
